1. Home
  2. GKOS vs TKC Comparison

GKOS vs TKC Comparison

Compare GKOS & TKC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$116.17

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Logo Turkcell Iletisim Hizmetleri AS

TKC

Turkcell Iletisim Hizmetleri AS

HOLD

Current Price

$6.88

Market Cap

5.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
TKC
Founded
1998
1993
Country
US
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.2B
IPO Year
2015
2001

Fundamental Metrics

Financial Performance
Metric
GKOS
TKC
Price
$116.17
$6.88
Analyst Decision
Strong Buy
Analyst Count
14
0
Target Price
$133.07
N/A
AVG Volume (30 Days)
770.3K
794.7K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
2.24%
EPS Growth
0.36
N/A
EPS
N/A
N/A
Revenue
$383,481,000.00
N/A
Revenue This Year
$23.29
$43.64
Revenue Next Year
$27.74
$28.36
P/E Ratio
N/A
$26.98
Revenue Growth
21.85
N/A
52 Week Low
$73.16
$5.35
52 Week High
$142.50
$7.60

Technical Indicators

Market Signals
Indicator
GKOS
TKC
Relative Strength Index (RSI) 52.32 62.09
Support Level $103.55 $6.44
Resistance Level $121.70 $7.18
Average True Range (ATR) 5.70 0.12
MACD -0.23 0.00
Stochastic Oscillator 63.83 58.75

Price Performance

Historical Comparison
GKOS
TKC

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About TKC Turkcell Iletisim Hizmetleri AS

Turkcell Iletisim Hizmetleri AS provides mobile telephone services in Turkey. The firm's services portfolio includes high-quality mobile and fixed voice, data, TV, and digital services over its network. The firm also operates in the Turkish Republic of Northern Cyprus, Belarus, the Netherlands, and Ukraine. It has three main reportable segments: Turkcell Turkiye, Turkcell International, and Techfin. The Turkcell Turkiye segment, which derives the majority of revenue, comprises mainly telecommunication and technology services activities.

Share on Social Networks: